Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
Crossref DOI link: https://doi.org/10.1186/s12913-017-2310-4
Published Online: 2017-05-26
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Polisena, Julie
Burgess, Michael
Mitton, Craig
Lynd, Larry D.
Funding for this research was provided by:
Canadian Agency for Drugs and Technologies in Health (C-150390)
Canadian Institutes for Health Research